Google
Trusted Resources: Community Center
Online support, community stories, financial assistance
The Coverage Battle Continues for Veterans With Transthyretin Amyloidosis
The Veterans Health Administration exists to integrate health care services for those who served in the U.S. Armed Forces. Yet for many veterans, getting access to treatment for transthyretin amyloidosis, a rare disease caused by a buildup of abnormal proteins, is difficult.
As a health system, the VA covers a large proportion of transthyretin amyloidosis patients because the condition usually presents in older adults, particularly older men. It is not a secret that medications used in the treatment of transthyretin amyloidosis are very expensive, and the VA does an excellent job in requiring patients to be responsible for only small monthly co-pay.
The VA has the opportunity to lead the way in providing patient-centered care for the historically untreatable disease. It should, however, work for best patients’ care rather than restricting physicians and limiting patients’ access.
Veterans with transthyretin amyloidosis are fighters, having first served their country and then forced to battle a progressive and rare disease. They shouldn’t have to also fight for access to the health care they rightfully earned.
myBinderRelated Content
-
Taimur Sher, MBBS, MDTaimur Sher is a Hematologist/Internist/...
-
Lentzsch: Bispecific Antibodies and Beyond in AL Amyloidosis – ASG AL Webinar 2.24.24 – 2/8https://www.youtube.com/watch?v=lzrMgtOC...
-
Craig C. Hofmeister, MD, MPHCraig C. Hofmeister is Associate Profess...
-
HealthWell Foundation Opens New Amyloidosis Fund to Assist Patients With Treatment CostsThe HealthWell Foundation, an independen...
-
Dr. Taimur Sher: Coping With Amyloidosis – ASG Webinar 5/6https://www.youtube.com/watch?v=CkBwTpXh...
-
Treatment for ATTR Cardiac Amyloid – ASG Webinar 2/11https://www.youtube.com/watch?v=K2TmwAfu...
-
Primary Brain Amyloidoma, Both a Neoplastic and a Neurodegenerative Disease: A Case ReportBackground: Scattered extracellular dep...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
